Prosperaize

Industries

AI in Life Sciences

For pharma and biotech, CROs and data companies, providers and healthtech: where AI pays, and what the data rules decide first.

01

Pharma & biotech

Much document work runs on the subscription you already have, once the data rules allow it. Answers that reach regulated records need a custom system.

03

Providers

Patient data decides first whether a cloud assistant is allowed at all. Most first uses are administrative, with a person checking every answer.

04

Healthtech

AI in what you sell is a custom build by definition, so it is tested on your data first, with safety designed in.

Before any tool

What has to exist first

Two questions often answer “no” here: can the data go to a cloud assistant, and can the tool change records freely? That forces a custom build. It doesn’t prove the value.

The dataThe data rules decide firstResidency, consent and health data decide what can run where, before any tool is chosen.
The ownersAn owner who also holds the validationEvery tool gets a named owner. In regulated processes the owner also holds the validation and the records.
The rulesRaised with the law firm before scopingHIPAA and GDPR; GxP and 21 CFR Part 11; medical device software rules and the EU AI Act.

Find out which of your AI cases the rules force up, and which pay.

Schedule a call with a partnerFree until 11 December